Diabetes technology

“Empowering Us”: A community-led survey of real-world perspectives of adults with type 1 diabetes using insulin pumps and continuous glucose monitoring to manage their glucose levels

Diabetes Res Clin PractPublished Cross-sectional study

Authors' conclusion

Technology is perceived by adults with T1D as important for managing glycaemia and emotional well-being. Modifiable barriers to use include affordability, and information regarding device suitability.

Study context

Population
Australian adults with T1D, current or past users of insulin pump therapy (IPT), real-time CGM (real-time continuous glucose monitoring (RT-CGM)) or intermittently scanned CGM (isCGM); mean age 45 ± 16 years, 62% female, diabetes duration 20 ± 14 years
Participants
3,380 completed surveys
Outcome
Perceptions of diabetes technology
Follow-up
November 2021 to January 2022
Methodological detailscommunity-led, online survey, 30-question
  • Community-led
  • Online survey
  • 30-question

Main finding

As reported in the abstract

Technology '(extremely) important' for maintaining target glucose levels
98%
Technology '(extremely) important' for reducing hypoglycaemia severity and frequency
93%
Positive contribution to emotional well-being, IPT
89%
Positive contribution to emotional well-being, RT-CGM
91%
Positive contribution to emotional well-being, isCGM
87%
Barrier: affordability, IPT
68%
Barrier: affordability, RT-CGM
81%
Barrier: affordability, isCGM
69%
Barrier: insufficient information for informed choices on device suitability, IPT
39%
Barrier: insufficient information for informed choices on device suitability, RT-CGM
41%
Barrier: insufficient information for informed choices on device suitability, isCGM
36%

Observational data: associations, not effects.

Further findings

Device experience

Experience with IPT
55%
Experience with RT-CGM
82%
Experience with isCGM
55%

Original publication

“Empowering Us”: A community-led survey of real-world perspectives of adults with type 1 diabetes using insulin pumps and continuous glucose monitoring to manage their glucose levels. Diabetes Res Clin Pract. Published 13 July 2023. doi:10.1016/j.diabres.2023.110830

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.